<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00976833</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00007879</org_study_id>
    <nct_id>NCT00976833</nct_id>
  </id_info>
  <brief_title>Standardized Rehabilitation for Intensive Care Unit (ICU) Patients With Acute Respiratory Failure</brief_title>
  <official_title>Standardized Rehabilitation for ICU Patients With Acute Respiratory Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wake Forest University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wake Forest University Health Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Acute Respiratory Failure (ARF) requiring mechanical ventilation affects 1.1 million of the&#xD;
      4.4 million people admitted to United States Intensive Care Units (ICU) every year. Patients&#xD;
      with ARF have an average ICU and hospital length of stay (LOS) of 8 and 15 days,&#xD;
      respectively, with median hospital costs greater than $30,000 United States. Patients with&#xD;
      ARF experience deconditioning, muscle weakness, joint contractures, dyspnea, depression, and&#xD;
      reduced health-related quality of life, all of which may contribute to prolonged&#xD;
      hospitalization and increased costs. Mechanistically, it is understood that patients with ARF&#xD;
      demonstrate acute inflammation which may contribute to the above cited problems. While the&#xD;
      investigators' research and that of others has shown that rehabilitation therapy can increase&#xD;
      functional outcomes while lowering biomarkers of inflammation in the frail aged and other&#xD;
      clinical populations, it is not known whether such rehabilitation therapy can result in&#xD;
      improved functional capacity and functional performance and reduce inflammation in ARF&#xD;
      patients. There is previous evidence for the feasibility and safety of rehabilitation therapy&#xD;
      in ARF patients. Therefore, the investigators propose a two-arm, randomized trial in 326&#xD;
      patients with ARF to compare Standardized Rehabilitation Therapy initiated in the ICU and&#xD;
      administered throughout the hospitalization versus usual care (control). Standardized&#xD;
      Rehabilitation Therapy will consist of: passive range of motion, physical therapy and&#xD;
      progressive resistance exercise (strength training). The regimen will be administered 7&#xD;
      days/week by a Mobility Team consisting of a critical care nurse, physical therapist and&#xD;
      nursing assistant.&#xD;
&#xD;
      The investigators will determine whether standardized rehabilitation therapy will reduce&#xD;
      hospital LOS, improve functional capacity and performance, improve quality of life, reduce&#xD;
      inflammation and reduce hospital costs as compared to usual care.&#xD;
&#xD;
      This study's primary objective is to determine whether standardized rehabilitation therapy&#xD;
      will decrease hospital length of stay.&#xD;
&#xD;
      Hypothesis: Compared to usual care, standardized rehabilitation therapy will reduce hospital&#xD;
      length of stay for patients with Acute Respiratory Failure.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2009</start_date>
  <completion_date type="Actual">June 2015</completion_date>
  <primary_completion_date type="Actual">October 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To determine whether standardized rehabilitation therapy will decrease hospital length of stay.</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">300</enrollment>
  <condition>Acute Respiratory Failure</condition>
  <arm_group>
    <arm_group_label>Usual Care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Usual Care</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standardized Rehabilitation</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Intervention arm to receive Standardized Rehabilitation Therapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standardized Rehabilitation</intervention_name>
    <description>3 component Rehabilitation approach, Passive Range of Motion, Physical Therapy and Progressive Resistance Training</description>
    <arm_group_label>Standardized Rehabilitation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Usual Care</intervention_name>
    <description>Usual Physical Therapy care</description>
    <arm_group_label>Usual Care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age â‰¥ 18 years&#xD;
&#xD;
          -  Mechanically ventilated via an Endotracheal tube or Bipap&#xD;
&#xD;
          -  Lung Injury&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Previously enrolled in TARGET STUDY&#xD;
&#xD;
          -  Inability to walk without assistance prior to acute ICU illness (use of a cane or&#xD;
             walker not exclusion)&#xD;
&#xD;
          -  Cognitive impairment prior to acute ICU illness (non-verbal)&#xD;
&#xD;
          -  Acute stroke&#xD;
&#xD;
          -  Body mass index (BMI) &gt; 50&#xD;
&#xD;
          -  Neuromuscular disease that could impair weaning&#xD;
&#xD;
          -  Hip fracture, unstable cervical spine or pathological fracture&#xD;
&#xD;
          -  Mechanically ventilated &gt; 80 hours&#xD;
&#xD;
          -  Current hospitalization or transferring hospital stay &gt; 7 days&#xD;
&#xD;
          -  Ineligible cancer treatment within the last 6 month&#xD;
&#xD;
          -  Moribund&#xD;
&#xD;
          -  Do Not Resuscitate(DNR)/Do Not Intubate(DNI) on admission&#xD;
&#xD;
          -  Other Research Study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter E. Morris, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wake Forest University Health Sciences</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Wake Forest University Health Sciences</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>September 11, 2009</study_first_submitted>
  <study_first_submitted_qc>September 11, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 14, 2009</study_first_posted>
  <last_update_submitted>August 8, 2018</last_update_submitted>
  <last_update_submitted_qc>August 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 10, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Acute Respiratory Failure</keyword>
  <keyword>Early ICU Mobility</keyword>
  <keyword>Early Physical Therapy</keyword>
  <keyword>Critical Care</keyword>
  <keyword>Intensive Care</keyword>
  <keyword>ICU</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Insufficiency</mesh_term>
    <mesh_term>Respiratory Distress Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

